Clicky

Vimian Group AB(VIMIAN)

Description: Vimian Group AB (publ) engages in the animal health business worldwide. It operates through Specialty Pharma, MedTech, Diagnostics, and Veterinary Services segments. The company offers proprietary diagnostics, prescription, and non-prescription treatments for preventive care and treatment of chronic conditions for companion animals under the Nextmune brand name; and molecular and immunodiagnostic solutions that are used by laboratories for veterinary specific applications with a focus on livestock and companion animal health markets under the Indical Bioscience brand name. It also provides procurement and tech-driven operations, such as online marketing, and education and HR, as well as a community for veterinary clinics through a membership-based platform under the VetFamily brand name; and orthopedic implants for veterinarians and universities under the Movora brand name. The company was incorporated in 2020 and is headquartered in Stockholm, Sweden.


Keywords: Online Marketing Chronic Condition Veterinary Medicine Veterinary Physician Molecular And Immunodiagnostic Solutions Veterinary Specific Applications

Home Page: vimian.com

Riddargatan 19
Stockholm, 11457
Sweden
Phone: 46 7 36 26 88 86


Officers

Name Title
Mr. Fredrik Ullman Chief Exec. Officer
Mr. Carl-Johan Zetterberg Boudrie Chief Financial Officer
Ms. Maria Dahllof Tullberg Head of IR, Communications & Sustainability
Mr. Carl-Johan Ehn Gen. Counsel
Mr. Magnus Kjellberg Chief Exec. Officer of Nextmune
Mr. Martin Bengtson Head of M&A
Mr. Stefano Santarelli Chief Exec. Officer of Indical Bioscience
Mr. Guy C. Sporri Co-Chief Exec. Officer of Movora
Mr. Alireza Tajbakhsh Head & CEO of VetFamily
Colleen Flesher Co-Chief Exec. Officer of Movora

Exchange: ST

Country: SE : Sweden

Currency: Swedish krone (kr)

Forward PE: 0
Trailing PE: 54
Price-to-Book MRQ: 3.2866
Price-to-Sales TTM: 46.9243
IPO Date:
Fiscal Year End: December
Full Time Employees: 885
Back to stocks